论文部分内容阅读
美国斯隆·凯特林纪念癌症中心(MSKCC)报告,修饰的单纯疱疹病毒(HSV)NV1020能有效治疗结直肠癌转移性肝癌。NV1020是由德国Medigene公司开发的用于治疗各种转移性肝癌的制剂。MSKCC进行的期临床研究包括12例传统一线治疗无效的转移性肝癌患者。一次输注病毒的结果显示,患者的平
The United States of America Sloan Kettering Memorial Cancer Center (MSKCC) reported that the modified herpes simplex virus (HSV) NV1020 is effective in the treatment of metastatic liver cancer in colorectal cancer. NV1020 is developed by the German company Medigene for the treatment of a variety of metastatic liver cancer preparations. The phase clinical studies conducted by MSKCC included 12 patients with metastatic HCC who were ineffective with traditional first-line therapy. The result of a single infusion of the virus shows that the patient is flat